What Parents Should Know About Leucovorin and Autism in 2026
The US government has approved leucovorin, a little-known drug, to address cerebral folate deficiency—a condition that may affect up to 40% of autistic individuals. While some doctors remain cautious due to limited evidence, a large-scale trial could provide clearer answers by mid-2026.
Why This Matters for Autism Families
Cerebral folate deficiency disrupts vitamin B9 absorption in the brain, potentially contributing to autism-related challenges like communication and sensory processing difficulties. If effective, leucovorin might offer a new supportive option for some children.
Key Considerations
- Pending Evidence: Current approval was based on small studies; the 2026 trial results will be critical for evaluating efficacy.
- Controversial Context: The decision aligns with the government's focus on autism under Robert F. Kennedy Jr.'s leadership, who has promoted disputed theories about autism causes.
Next Steps for Parents
- Discuss folate deficiency testing with your child's doctor if they have unexplained autism symptoms.
- Monitor trial updates through reliable medical sources before considering new treatments.
As we await more data, remember: Always consult your healthcare team before pursuing emerging therapies.
Source: www.newscientist.com
